RNAConnect, Inc
- Biotech or pharma, animal health
- Medical device or technology
- Other products or services
- Biotech or pharma, therapeutic R&D
RNAConnect is a life science tools company redefining what’s possible in transcriptomics.
The RNA field is exploding, fueled by new technologies and methods. Despite this, nearly every RNA analysis starts with a 25-year-old challenge: cDNA synthesis with retroviral reverse transcriptases (RT) that distort actual biology by producing incomplete or misleading cDNA.
We’ve now broken that barrier with UltraMarathonRT® (uMRT), a next-generation RT that delivers end-to-end cDNA synthesis from any RNA regardless of length, structure, or complexity. Engineered from a group II intron RT, uMRT eliminates the fragmentation, drop-offs, and splicing artifacts introduced by retroviral RTs, offering a dramatically more complete and accurate view of the transcriptome for:
- Greater isoform and gene detection
- Superior detection of intron retention and noncoding RNAs
- Enhanced RT-qPCR quantification accuracy
- Better resolution of RNA structure
In short, uMRT expands what scientists can see—and what they can solve.



